https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43746 Wed 28 Sep 2022 10:57:43 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53945 Wed 28 Feb 2024 14:46:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18332 Wed 24 Jun 2015 10:31:54 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8310 Wed 24 Jul 2013 22:47:37 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38843 n = 6492) from government schools in New South Wales, Australia, completed an annual online survey. Their individual responses were linked with prior academic achievement and demographic data. Logistic regression models were used to examine the significance of student- and school-related variables as predictors of interest in medicine. Results: Significant predictors were: being in the early years of secondary school, possessing high cultural capital, coming from a language background other than English, being female, and perceiving oneself as 'well above average' relative to peers. Socio-economic status was a significant predictor when examined independently, but not when all variables were considered in the full regression model. Conclusions: For medical schools seeking to widen participation, this study underscores the importance of recognising the intersection of other factors with socio-economic status and how they contribute to students¿ aspirational biographies. If medical schools are to select from a more diverse range of applicants, recruitment strategies must take into account the discursive positioning of the discipline. Sustained outreach into primary and secondary schools may be critical to interrupting the current social reproduction of medical schooling.]]> Wed 16 Feb 2022 09:59:41 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16793 Wed 11 Apr 2018 18:23:59 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22250 Wed 11 Apr 2018 17:20:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4373 Wed 11 Apr 2018 17:19:57 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4569 Wed 11 Apr 2018 16:57:52 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23642 Wed 11 Apr 2018 15:21:29 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13751 Wed 11 Apr 2018 12:40:01 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22619 Wed 11 Apr 2018 12:02:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4284 Wed 11 Apr 2018 09:27:52 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32654 school climate and related concepts such as school connectedness and school belonging (e.g., Thapa, Cohen, Higgins-D'Alessandro and Guffey, 2013). School climate is defined in different ways, but in essence, it focuses on student perceptions of academic emphasis, the way groups within a school (e.g., teachers, students, parents) relate to one another, and the higher-order norms, values, and practices (shared mission) that define the school as a whole (Thapa et al., 2013). In this chapter, we argue that incorporating a social-psychological analysis of the group within the school climate domain can advance understanding of school life. To date, most emphasis is placed on the psychology of individuals-as-individuals and interpersonal relationships. What is missing is an analysis of the group.]]> Wed 04 Jul 2018 16:50:11 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50424 Tue 25 Jul 2023 18:41:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18086 Tue 23 Jun 2015 11:35:57 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37787 Tue 20 Apr 2021 14:32:36 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47005 Tue 13 Dec 2022 11:13:29 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21952 Tue 11 Dec 2018 14:54:13 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52391 Tue 10 Oct 2023 14:47:07 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41637 Tue 09 Aug 2022 15:06:19 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18413 Thu 25 Jun 2015 10:27:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18412 Thu 25 Jun 2015 10:20:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18411 Thu 25 Jun 2015 10:13:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18410 Thu 25 Jun 2015 09:03:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18408 Thu 25 Jun 2015 08:42:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18407 Thu 25 Jun 2015 08:35:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18406 Thu 25 Jun 2015 08:28:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31150 Thu 17 Feb 2022 09:28:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37418 Thu 12 Nov 2020 17:45:51 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55035 Thu 04 Apr 2024 11:11:07 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6939 Sat 24 Mar 2018 10:46:37 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7500 Sat 24 Mar 2018 08:38:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7014 Sat 24 Mar 2018 08:38:04 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17047 Sat 24 Mar 2018 08:05:06 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16061 Sat 24 Mar 2018 08:03:43 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18405 Sat 24 Mar 2018 07:59:51 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:6609 Sat 24 Mar 2018 07:46:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:389 Sat 24 Mar 2018 07:42:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55 Sat 24 Mar 2018 07:42:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29002 Sat 24 Mar 2018 07:41:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29003 Sat 24 Mar 2018 07:41:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29005 Sat 24 Mar 2018 07:41:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29001 formal approach to understanding the real world through a simplified external and explicit representation of a mental model which can be manipulated and tested, before being implemented back into the real world. Mikulecky described the underlying mental processes as summarised in Fig. 6.1.]]> Sat 24 Mar 2018 07:41:18 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28999 Sat 24 Mar 2018 07:41:18 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29359 Sat 24 Mar 2018 07:34:17 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30648 n = 5; 33%), course coordinators (n = 4; 27%), Heads of School (n = 2; 13%), one Dean (7%), and three others (20%). Most schools (n = 9; 60%) reported 0-5 hours dedicated to teaching LGBTQI content during the required pre-clinical phase; nine schools (60%) reported access to a clinical rotation site where LGBTQI patient care is common. In most schools (n = 9; 60%), LGBTQI-specific content is interspersed throughout the curriculum, but five schools (33%) have dedicated modules. The most commonly used teaching modalities include lectures (n = 12; 80%) and small-group sessions (n = 9; 60%). LGBTQI content covered in curricula is varied, with the most common topics being how to obtain information about same-sex sexual activity (80%) and the difference between sexual behavior and identity (67%). Teaching about gender and gender identity is more varied across schools, with seven respondents (47%) unsure about what is taught. Eight respondents (53%) described the coverage of LGBTQI content at their institution as "fair," two (13%) as "good," and two (13%) as "poor," with one respondent (7%) describing the coverage as "very poor." None of the respondents described the coverage as "very good." Conclusions: Currently, medical schools include limited content on LGBTQI health, most of which focuses on sexuality. There is a need for further inclusion of curriculum related to transgender, gender diverse, and intersex people.]]> Sat 24 Mar 2018 07:33:22 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28960 Sat 24 Mar 2018 07:29:32 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28319 Ganoderma lucidum (also known as lingzhi or reishi) is a mushroom that has been consumed for its broad medicinal properties in Asia for over 2000 years. G lucidum is becoming increasingly popular in western countries as a complementary medicine for cardiovascular health. Objectives: To evaluate the effectiveness of G lucidum for the treatment of pharmacologically modifiable risk factors of cardiovascular disease in adults.Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL Issue 6 of 12, 2014) on The Cochrane Library, MEDLINE (OVID, 1946 to June week 3 2014), EMBASE (OVID, 1980 to 2014 week 26), Science Direct (1823 to 2013), Current Controlled Trials (1990 to 2013), Australian New Zealand Clinical Trials Registry (2005 to 2013), Chinese Biomedical Literature Database (2007 to 2013), Chinese Medical Current Contents (2007 to 2013) and other databases. We checked reference lists of included studies, contacted content experts and handsearched The International Journal of Medicinal Mushrooms. We applied no language or publication restrictions. Selection criteria: Randomised controlled trials and controlled clinical trials of G lucidum for the treatment of cardiovascular risk factors. Primary outcomes were blood glucose level, blood pressure and lipid profile. Data collection and analysis: Two authors independently selected trials, assessed risk of bias and cross checked data extraction and analysis. A third author arbitrated in the event of disagreement. Main results: Five trials with a total of 398 participants were eligible for inclusion. Of these, one study was published in Chinese and translated to English; one study was published but study authors provided the additional data used in this review; one study was unpublished and the study authors provided data; and two studies did not provide comparison group data suitable for statistical analyses. The three studies from which data were used for statistical analyses compared G lucidum (1.4 g to 3 g per day) to placebo over 12 to 16 weeks of intervention. Although inclusion criteria varied, all participants of these three studies had type 2 diabetes mellitus. Of the five included studies, risk of bias was low for one study and unclear for the remaining four. Results from two studies showed that G lucidum was not associated with statistically or clinically significant reduction in HbA1c (WMD -0.10%; 95% CI -1.05% to 0.85%; 130 participants), total cholesterol (WMD -0.07mmol/L; 95% CI -0.57 mmol/L to 0.42 mmol/L; 107 participants ), low-density lipoprotein cholesterol (WMD 0.02 mmol/L; 95% CI -0.41 mmol/L to 0.45 mmol/L; 107 participants), or body-mass index (WMD -0.32 kg/m²; 95% CI -2.67 kg/m² to 2.03 kg/m²; 107 participants). All other analyses were from a single study of 84 participants. We found no improvement for fasting plasma glucose (WMD 0.30 mmol/L; 95% CI -0.95 mmol/L to 1.55 mmol/L). Measures of post-prandial blood glucose level found inconsistent results, being in favour of placebo for '2-hour post-prandial blood glucose' (WMD 0.7 mmol/L; 95% CI 0.29 mmol/L to 1.11 mmol/L) and in favour of G lucidum for 'plasma glucose under the curve at 4th hour' (WMD -49.4mg/dL/h; 95% CI -77.21 mg/dL/h to -21.59 mg/dL/h). As the Minimal Clinical Important Differences are unknown, the clinical significance of this effect is unclear. There were no statistically significant differences between groups for blood pressure or triglycerides. Participants who took G lucidum for four months were 1.67 times (RR 1.67 95% CI 0.86 to 3.24) more likely to experience an adverse event than those who took placebo but these were not serious side effects. Authors' conclusions: Evidence from a small number of randomised controlled trials does not support the use of G lucidum for treatment of cardiovascular risk factors in people with type 2 diabetes mellitus. Future research into the efficacy of G lucidum should be placebo-controlled and adhere to clinical trial reporting standards.]]> Sat 24 Mar 2018 07:25:08 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:3951 Sat 24 Mar 2018 07:22:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30694 Mon 23 Sep 2019 13:58:52 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53901 Mon 22 Jan 2024 15:03:36 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53898 Mon 22 Jan 2024 15:03:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47381 Mon 16 Jan 2023 13:46:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52273 Mon 09 Oct 2023 10:04:34 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41322 Mon 01 Aug 2022 15:46:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53035 Fri 08 Dec 2023 09:32:37 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29199 Myoporaceae, which includes the genus Myoporum, are extremely prized by the Australian Aboriginal people for their medicinal properties. Leaves from a plant, which was subsequently identified as Myoporum montanum, were provided for chemical investigation by representatives of an Aboriginal community from the Northern Tablelands district of northern New South Wales, Australia. Acetone extraction of the leaves provided a complex mixture of compounds including sesquiterpene hydrocarbons and more polar furanosesquiterpenes, which were identified by gas-liquid chromatography and retention indices (sesquiterpene hydrocarbons) and spectrometric techniques (furanosesquiterpenes). The major compounds found in a water extract were studied for their antibacterial activity using a disc diffusion assay and for their cell growth inhibition activity. The acetone extract contained sesquiterpene hydrocarbons (~30% of the total extract) in which the major compounds were germacrene-D and bicyclogermacrene. In addition, the extract contained five known toxic furanosesquiterpenes: myoporum ketol, (-)-10,11-dehydroisomyodesmone, (+)-10,11-dehydromyodesmone, 10,11-dehydromyoporum ketol, (-)-10,11-dehydromyoporone, and (±)-myoporone. An aqueous extract of the leaves, emulating the medicinal tea used by the Australian Aboriginal community, was found not to contain significant quantities of the sesquiterpene hydrocarbons and the most toxic furanosesquiterpenes. (±)-Myoporone and (-)-10,11-dehydromyoporone remained in the extract as well as a new furanosesquiterpene, 11-hydroxymyoporone. These three compounds were found to have significant antibacterial activity against Staphylococcus epidermidis, Enterococcus faecalis, and Moraxella catarrhalis but low cytotoxicity against a range of cancer cell lines and normal breast cells at 25µM.]]> Fri 01 Apr 2022 09:25:59 AEDT ]]>